ROKIT Healthcare Files U.S. Patent and PCT Applications for Telomere Protection Composition

Related new products to launch in the U.S. and South Korea in October
Cell-level study results disclosed

ROKIT Healthcare's U.S. subsidiary, ROKIT America, has completed filings for a U.S. patent and an international patent application (PCT) covering a compound composition related to telomere protection, and is setting its sights on the longevity market, focused on extending lifespan and healthspan.

ROKIT America said on October 22 that it plans to launch products under a specialized telomere brand using the composition in the U.S. and South Korean markets this October. The new product is set to debut first in the U.S. as a dietary supplement.

ROKIT America Telomere product image. ROKIT Healthcare.

The composition combines vitamin C with cycloastragenol (CAG) and astragaloside IV (AS-IV), both derived from astragalus, and epigallocatechin gallate (EGCG), derived from green tea. The company has named it the "ROKIT TELO Active Blend." This follow-up filing supplements a patent application for the compound composition filed in the U.S. in September 2025, adding claims related to telomere protection.

According to the company, cell experiments showed that the composition had a telomere protection rate of 66.5%. The protection rates of individual ingredients were 0.3-14.8% compared with the normal control group. These findings were confirmed in in vitro studies, and the company plans to assess the composition's efficacy and safety in humans in the future.

Telomeres are structures that protect the ends of chromosomes and tend to shorten as cells divide. Research that elucidated how telomeres and telomerase work led to the 2009 Nobel Prize in Physiology or Medicine.

A ROKIT America representative said, "This patent filing is the first step in expanding our longevity product lineup with a compound composition designed through our own research. We will build a PPR (Predictive, Preventive, and Regenerative) platform that connects AI-based health indicator analysis with everyday health management and personalized regeneration."

This content was produced with the assistance of AI translation services.